首页> 外文期刊>Arthritis and Rheumatism >Lymphocytotoxic antibodies in systemic lupus erythematosus patients and their relatives
【24h】

Lymphocytotoxic antibodies in systemic lupus erythematosus patients and their relatives

机译:Lymphocytotoxic antibodies in systemic lupus erythematosus patients and their relatives

获取原文
           

摘要

AbstractLymphocytotoxic activity of sera from systemic lupus erythematosus (SLE) patients and their families was inhibited by 50% or more by preincubation of target cells with Fab2fragments of xenoantisera against β2microglobulin or the heavy chain of the HLA‐A,B,C antigenic molecular complex. An antiHLA‐DR xenoantiserum had less blocking effect on peripheral blood mononuclear cells but was effective at blocking reactivity of these sera against cultured B lymphoid cell lines. The repertoire of specificities in family members' sera differed from each other and their respective proband with respect to their reactions with cultured lymphoid cell lines. These data indicate that lymphocytotoxic antibodies (LCA) found in most patients with SLE and some of their relatives include a subpopulation with specificity for determinants present on major histocompatibility gene products. They also suggest that LCA in relatives represent a defect in immune regulation which allows expression of existing autoimmune potentials rather than immunization with a single ‘lupus’

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号